1. Welcome to Pit Bull Chat!

    You are currently viewing our boards as a guest which gives you limited access to view most discussions and access our other features. By joining our free community, you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, join our community today!

    If you have any problems with the registration process or your account login, please contact us.

    Dismiss Notice

Update to Voluntary Recall of Eliquis® (apixaban) 5 mg Tablets (#HN0063) - Recall to...

Discussion in 'FDA Recalls' started by Food and Drug, Jun 17, 2017.

  1. On June 10, Bristol-Myers Squibb announced a voluntary recall of one lot (#HN006:relievedface: of Eliquis 5 mg tablets. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a single customer complaint that a bottle labeled as Eliquis5 mg was found to contain Eliquis 2.5 mg tablets. No other lots are impacted by this recall.

    Continue reading...
     

Share This Page